Parameters for Pyrethroid Insecticide QSAR and PBPK/PD Models for Human Risk Assessment

  • James B. Knaak
  • Curtis C. Dary
  • Xiaofei Zhang
  • Robert W. Gerlach
  • R. Tornero-Velez
  • Daniel T. Chang
  • Rocky Goldsmith
  • Jerry N. Blancato
Chapter
Part of the Reviews of Environmental Contamination and Toxicology book series (RECT, volume 219)

Abstract

This pyrethroid insecticide parameter review is an extension of our interest in developing quantitative structure–activity relationship–physiologically based pharmacokinetic/pharmacodynamic (QSAR-PBPK/PD) models for assessing health risks, which interest started with the organophosphorus (OP) and carbamate insecticides (Knaak et al. 2004, 2008). The parameters shown in Table 1 (Blancato et al. 2000) are needed for developing pyrethroid PBPK/PD models, as is information on the metabolic pathways of specific pyrethroids in laboratory test animals and humans. Parameters may be obtained by fitting the output from models to experimental data gathered from in vivo studies (Zhang et al. 2007; Nong et al. 2008), in conjunction with using (1) experimental data obtained from in vitro studies, (2) quantitative structure–activity relationships (QSAR) and (3) other mathematical models, such as the mechanistic Poulin-Theil (2000; 2002a; b) algorithms for obtaining blood:tissue partition coefficients.

References

  1. Abernathy CO, Casida JE (1973) Pyrethroid insecticides: esterase cleavage in relation to selective toxicity. Science 179:1235–1236Google Scholar
  2. Ackermann P, Bourgeois F, Drabek J (1980) The optical isomers of alpha-cyano-3-phenoxybenzyl 3-1,2-dibromo-2,2-dichloroethyl-2,2-dimethylcyclopropanecarboxylate and their insecticidal activities. J Pestic Sci 11:169–179Google Scholar
  3. Agoram B, Woltosz WS, Bolger MB (2001) Predicting the impact of physiological and biochemical processes on oral drug bioavailability. Adv Drug Deliver Rev 50:S41–S67Google Scholar
  4. Allen S, Leah A (1990) Lambda-cyhalothrin: acute oral toxicity study in the rat. Zeneca Agricultural Products Laboratory No. CTL/P/3209:AR4840, Wilmington, DE.Google Scholar
  5. Anadon A, Martinez-Larranaga MR, Fernandez-Cruz ML, Diaz MJ, Fernadez MC, Martinez MA (1996) Toxicokinetics of deltamethrin and its 4′-OH-metabolite in the rat. Toxicol Appl Pharmacol 141:8–16Google Scholar
  6. Anand SS, Bruckner JV, Haines WT, Muralidhara S, Fisher JW, Padilla S (2006) Characterization of deltamethrin metabolism by rat plasma and liver microsomes. Toxicol Appl Pharmacol 212:156–166Google Scholar
  7. Andersen ME, Dennison JE (2001) Mode of action and tissue dosimetry in current and future risk assessments. Sci Total Environ 274(1–3):3–14Google Scholar
  8. Angerer J, Ritter A (1997) Determination of metabolites of pyrethroids in human urine using solid-phase extraction and gas chromatography-mass spectrometry. J Chromatogr 695:217–226Google Scholar
  9. Artursson P, Palm K, Luthan K (1996) Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev 22:67–84Google Scholar
  10. Audegond L, Collas E, Glomot R (1981a) RU 25474 (tralomethrin) single administration study by oral route in the rat. Study No. RU-4BE-81.240/A, Roussel-Uclaf, Paris.Google Scholar
  11. Audegond L, Collas E, Glomot R (1981b) RU 25474 (tralomethrin) single administration study by oral route in the rat. Study No. 81240 DS/84/A, Roussel-Uclaf, Paris.Google Scholar
  12. Austin RP, Barton P, Cockroft SL, Wenlock MC, Riley RJ (2002) The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties. Drug Metab Dispos 30:1497–1503Google Scholar
  13. Baker H, Kligman AM (1967) Measurement of transepidermal water loss by electrical hygrometry. Arch Dermatol 96:441–452Google Scholar
  14. Barbero AM, Frasch HF (2009) Pig and guinea pig skin as surrogates for human in vitro penetration studies: a quantitative review. Toxicol In Vitro 23:1–13Google Scholar
  15. Barrueco D, Herrera A, Caballo C, Delapena E (1992) Cytogenic effects of permethrin in cultured human-lymphocytes. Mutagenesis 7:433–437Google Scholar
  16. Barter ZE, Bayliss MK, Beaune PH, Boobis AR, Carlile DJ, Edwards RJ, Houston JB, Lake BG, Lipscomb JC, Pelkonen OR, Tucker GT, Rostami-Hodjegan A (2007) Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver. Curr Drug Metab 8:33–45Google Scholar
  17. Bast GE, Taeschner D, Kampffmeyer HG (1997) Permethrin absorption not detected in single-pass perfused rabbit ear, and absorption with oxidationof 3-phenoxybenzyl alcohol. Arch Toxicol 71:179–186Google Scholar
  18. Baynes RE, Halling KB, Riviere JE (1997) The influence of Diethyl-m-toluamide (DEET) on the percutaneous absorption of permethrin and carbaryl. Toxicol Appl Pharmacol 144:332–339Google Scholar
  19. Berenson GS, Burch GE (1951) Studies of diffusion through dead human skin. Am J Trop Med Hyg 31:842–853Google Scholar
  20. Berezhkovskly LM (2004a) Determination of volume of distribution at steady state with complete consideration of the kinetics of protein and tissue binding in linear. J Pharm Sci 93:364–364Google Scholar
  21. Berezhkovskly LM (2004b) Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination. J Pharm Sci 93:1628–1640Google Scholar
  22. Berezhkovskly LM (2007) The connection between the steady state (Vss) and Terminal (Vβ) volumes of distribution in linear pharmacokinetics and the general proof that Vβ ≥ Vss. J Pharm Sci 96:1638–1650Google Scholar
  23. Bilsback MM, Parker CM, Wimberly HC (1984) Comparative oral toxicity of technical MO70616 and technical SD 42775 in rats. Study No. WRC-RIR 357.Corporation Study No. NCT584.01, Shell Development Company, Houston, TX.Google Scholar
  24. Blancato JN, Knaak JB, Power F (2000) Use of PBPK models for assessing absorbed dose and ChE inhibition from aggregate exposure of infants and children to organophosphorous insecticides. Presented at 10th Annual Meeting of the International Society of Exposure Analysis, Monterey, CA (Abstract 3F-09o)Google Scholar
  25. Bloomquist JR, Soderlund DM (1988) Pyrethroid insecticides and DDT modify alkaloid-dependent sodium channel activation and its enhancement by sea anemone toxin. Mol Pharmacol 33:543–550Google Scholar
  26. Boatman RJ, Knaak JB (2001) Ethers of ethylene glycol and derivatives. In: Bingham E, Cohrsson B, Powell CH (eds) Patty’s toxicology (5th ed). Wiley, NY, NYGoogle Scholar
  27. Bolger MB (2010) Simulations-Plus, Inc., Lancaster, CA. Memo to Kurt Enslein, Enslein Research, Rochester, NY.Google Scholar
  28. Breckenridge CB, Holden L, Sturgess N, Weiner M, Sheets L, Sargent D, Soderlund DM, Choi J-S, Symington S, Clark JM, Burr S, Ray D (2009) Evidence for a separate mechanism of toxicity for the Type I and the Type II pyrethroid insecticides. Neurotoxicology 30(Suppl 1):S17–S31Google Scholar
  29. Bronaugh RL, Stewart RF, Congdon ER (1982) Methods for in vitro percutaneous absorption studies II. Animal models for human skin. Toxicol Appl Pharmacol 62:481–488Google Scholar
  30. Bronaugh RL, Stewart RF, Simon M (1986) Methods for in vitro percutaneous absorption studies. VII: use of excised human skin. J Pharm Sci 75:1094–1097Google Scholar
  31. Brown RP, Delp MD, Lindstedt SL, Rhomberg LR, Beliles RP (1997) Physiological parameter values for physiologically based pharmacokinetic models. Toxicol Ind Health 13:407–484Google Scholar
  32. Burr SA, Ray DE (2004) Structure-activity and interaction effects of 14 different pyrethroids on voltage-gated chloride ion channels. Toxicol Sci 77:341–346Google Scholar
  33. Cahn RS, Ingold CK, Prelog V (1966) Specification of chirality. Angew Chem Int Ed Engl 5:385–415Google Scholar
  34. Casida JE, Kimmel EC, Elliott M, Janes NF (1971a) Oxidative metabolism of pyrethrins in mammals. Nature 230:326–327Google Scholar
  35. Casida JE, Kimmel ED, Elliott M, Janes NF (1971b) Oxidative metabolism of pyrethrins in mammals. Pyrethrum Post 11:58–59Google Scholar
  36. Casida JE, Ueda K, Gaughan LC, Jao LT, Soderlund DM (1975) Structure-biodegradability relationships in pyrethroid insecticides. Arch Environ Contam Toxicol 3:491–500Google Scholar
  37. Cayley GR, Simpson BW (1986) Separation of pyrethroid enantiomers by chiral high-performance liquid chromatography. J Chromatogr A 356:123–134Google Scholar
  38. Chamberlain K, Matsuo N, Kaneko H, Khambay BPS (1998) Pyrethroids. In: Chirality in agrochemicals. Wiley, New YorkGoogle Scholar
  39. Chang JH, Benet LZ (2005) Glucuronidation and the transport of the glucuronide metabolites in LLC-PK1 cells. Mol Pharmacol 2:428–434Google Scholar
  40. Chang SK, Brooks JB, Monteiroriviere NA, Riviere JE (1995) Enhancing or blocking effect of fenvalerate on the subsequent percutaneous absorption of pesticides in vitro. Pestic Biochem Physiol 51:214–219Google Scholar
  41. Chang DT, Goldsmith M-R, Tornero-Velez L-J, Ulrich E, Lindstrom AB, Dary CC (2009) A novel application of QSAR and PH4 models for the elucidation of the stereoselective hydrolysis rates of pyrethroids by rat serum carboxylesterase. Society of Environmental Toxicology and Chemistry, New Orleans, LA, November 2009 meeting.Google Scholar
  42. Chemical Abstracts Service (2002) Chemical abstracts 2002 index guide, appendix IV, naming and indexing of chemical substances for chemical abstracts, E. Stereochemistry and stereoparents (paragraphs 202–212). Chemical Abstracts Service, Columbus, Ohio.Google Scholar
  43. Choi J-S, Soderlund DM (2006) Structure-activity relationships for the action of 11 pyrethroid insecticides on rat Nav1.8 sodium channels expressed in Xenopus oocytes. Toxicol Appl Pharmacol 211:233–244Google Scholar
  44. Clark JM, Brooks MW (1989) Role of ion channels and intraterminal calcium homeostasis in the action of deltamethrin at presynaptic nerve terminals. Biochem Pharmacol 38:2233–2245Google Scholar
  45. Class TJ, Ando T, Casida JE (1990) Pyrethroid metabolism: microsomal oxidase metabolites of (S)-bioallethrin and the six natural pyrethrins. J Agric Food Chem 38:529–537Google Scholar
  46. Cole LM, Ruzo LO, Wood EJ, Casida JE (1982) Pyrethroid metabolism: comparative fate in rats of tralomethrin, tralocythrin, deltamethrin, and (1R, alphaS)-cis-cypermethrin. J Agric Food Chem 30:631–636Google Scholar
  47. Colmenarejo G (2003) In silico prediction of drug-binding strengths to human serum albumin. Med Res Rev 23:275–301Google Scholar
  48. Colmenarejo G, Alverez-Pedraglio A, Lavandera J (2001) Cheminformatic models to predict binding affinities to human serum albumin. J Med Chem 44:4370–4378Google Scholar
  49. Cramer RD, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110:5959–5967Google Scholar
  50. Crane AL, Browner RW, Knaak JB, Bonner MR, Fenske RA, Farahat FM, Anger WK, Lein PJ, Olson JR (2011) Inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) in human blood following in vitro and in vivo exposure to chlorpyrifos. Abstract No. 1243, 49th Annual Meeting and ToxExpo, Salt Lake City, Utah, March 7–11.Google Scholar
  51. Crawford MJ, Hutson DH (1977) The metabolism of the pyrethroid insecticide (±)-α-cyano-3-phenoxybenzyl 2, 2, 3, 3-tetramethylclyclopropanecarboxylate, WL 41706, in the rat. Pestic Sci 8:579–599Google Scholar
  52. Crawford MJ, Croucher A, Hutson DH (1981a) Metabolism of cis- and trans-cypermethrin in rats. Balance and tissue retention study. J Agric Food Chem 29:130–135Google Scholar
  53. Crawford MJ, Croucher A, Hutson DH (1981b) The metabolism of the pyrethroid insecticide cypermethrin in rats: excreted metabolites. Pestic Sci 12:399–411Google Scholar
  54. Crow JA, Borazjani A, Potter PM, Ross MK (2007) Hydrolysis of pyrethroids by human and rat tissues: examination of intestinal, liver and serum carboxylesterases. Toxicol Appl Pharmacol 221:1–12Google Scholar
  55. Culliford SJ, Borg JJ, O’Brien MJ, Kozlowski RZ (2004) Differential effects of pyrethroids on volume-sensitive anion and organic osmolyte pathways. Clin Exp Pharmacol Physiol 31:134–144Google Scholar
  56. Danker T, Mazzanti M, Tonini R, Rakowska A, Oberleithner H (1997) Using the atomic force microscopy to investigate patch-clamped nuclear membrane. Cell Biol Int 21:747–757Google Scholar
  57. Davies B, Morris T (1993) Physiological parameters in laboratory animals and humans. Pharm Res (NY) 10:1093–1095Google Scholar
  58. Delie F, Rubas W (1997) A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Crit Rev Ther Drug Carrier Syst 14:221–286Google Scholar
  59. L’Hoste J (ed) (1982) Deltamethrin monograph. Roussel-Uclaf, ParisGoogle Scholar
  60. Diel F, Detscher M, Schock B, Ennis M (1998) In vitro effects of the pyrethroid S-bioallethrin on lymphocytes and basophils from atopic and nonatopic subjects. Allergy 53:1052–1059Google Scholar
  61. Eadsforth CV, Baldwin MK (1983) Human dose-excretion studies with pyrethroid insecticide, cypermethrin. Xenobiotica 13:67–72Google Scholar
  62. Eadsforth CV, Bragt PC, Sittert NJ (1988) Human dose-excretion studies with pyrethroid insecticides: cypermethrin and alpha cypermethrin: relevance for biological monitoring. Xenobiotica 18:603–614Google Scholar
  63. EC-HCPDG (2002) European Commission, Health & Consumer Protection Directorate-General, Directorate E1: Plant Health. Beta-Cyfluthrin, Review Report # 6841/VI/97-final, 12-2-2002.Google Scholar
  64. Eells JT, Bandettini PA, Holman PA, Propp JM (1992) Pyrethroid insecticide-induced alterations in mammalian synaptic membrane-potential. J Pharmacol Exp Ther 262:1173–1181Google Scholar
  65. Eldefrawi ME, Sherby SM, Abalis IM, Eldefrawi AT (1985) Interactions of pyrethroid and cyclodiene insecticides with nicotinic acetylcholine and GABA receptors. Neurotoxicology 6:47–62Google Scholar
  66. Elflein L, Berger-Preiss E, Preiss A, Elend M, Levsen K, Wunsch G (2003) Human biomonitoring of pyrethroid insecticides used indoors: determination of the metabolites E-cis/trans-chrysanthemum dicarboxylic acid in human urine by gas chromatography-mass spectrometry with negative chemical ionizations. J Chromatogr B 795:195–207Google Scholar
  67. Elliott M (1989) The pyrethroids: early discovery, recent advances and the future. Pestic Sci 27:337–351Google Scholar
  68. Elliott M, Janes NF (1978) Synthetic pyrethroids: a new class of insecticide. Chem Soc Rev 7:473–505Google Scholar
  69. Elliott M, Farnham AW, Janes NF, Needham PH, Pearson BC (1967) 5-Benzyl-3-furylmethyl chrysanthemate a new potent insecticide. Nature (London) 213:493–494Google Scholar
  70. Elliott M, Janes NF, Kimmel EC, Casida JE (1972) Metabolic fate of pyrethrin I, pyrethrin II, and allethrin administered orally to rats. J Agric Food Chem 20:300–313Google Scholar
  71. Elliott M, Farnham AW, Janes NF, Needhan DH, Pulman DA (1974) Synthetic insecticides with a new order of activity. Nature (London) 248:710–711Google Scholar
  72. Elliott M, Janes NF, Pulman DA, Gaughan LC, Unai T, Casida JE (1976) Radiosynthesis and metabolism in rats of the 1R-isomers of the insecticide permethrin. J Agric Food Chem 24:270–276Google Scholar
  73. Elliott M, Janes NF, Potter C (1978) The future of pyrethroids in insect control. Ann Rev Entomol 23:443–469Google Scholar
  74. Ellison CA, Knaak, JB, McDougall R, Lein PJ, Farahat FM, Anger WK, Olson JR (2011) Construction and validation of a human PBPK/PD model for dermal chlorpyrifos exposure utilizing human biomarker data. Abstract No. 2106, 50th Annual Meeting and ToxExpos, Washington, DC, March 6–10.Google Scholar
  75. Enan E, Matsumura F (1993) Activation of phosphoinositide protein-kinase-c pathway in rat-brain tissue by pyrethroids. Biochem Pharmacol 45:703–710Google Scholar
  76. Enslein K (2010) ADMET predictor. Simulations-Plus, Lancaster, CAGoogle Scholar
  77. Enslein K, Gombar VK, Shapiro D, Blake BW (1998) Prediction of rat oral LD50 values of chemicals by QSAR equations. TOPKAT Health Designs, Rochester, NYGoogle Scholar
  78. Enslein K, Knaak JB, Van Nostrand K, Susa R, Koestler D (2007) CYP3A4 hydroxylation kinetics: QSAR models with application to PBPK modeling. J Comput Aided Mol Des. An internal document-Enslein Research, Inc., Rochester, NY. (submitted).Google Scholar
  79. Farahat FM, Ellison CA, Bonner MR, McGarrigle BP, Crane AL, Fenske RA, Lasarev MR, Rohlman DS, Anger WK, Lein PJ, Olson JR (2011) Biomarkers of chlorpyrifos exposure and effect in Egyptian cotton field workers. Environ Health Perspect 119:801–816Google Scholar
  80. Farahmand S, Maibach HI (2009) Estimating skin permeability from physicochemical characteristics of drugs: a comparison between conventional models and an in vivo-based approach. Int J Pharm 375:41–47Google Scholar
  81. Faraoni M, Messina A, Polcaro CM, Aturki Z, Sinibaldi M (2004) Chiral separation of pesticides by coupled-column liquid chromatography application to the stereoselective degradation of fenvalerate in soil. J Liq Chromatogr Rel Technol 27:995–1012Google Scholar
  82. Feldmann RJ, Maibach HI (1974) Percutaneous penetration of some pesticides and herbicides in man. Toxicol Appl Pharmacol 28:126–132Google Scholar
  83. Fisher JB, Debray PH, Robinson J (1983) In: Plant Protection for Human Welfare, Proc 10th Internat Congr Plant Prot Vol 1, BCPC, Croydon, UK, 1983, pp 452–459. FMC, U.S. Patent 4,262,921 (1981)Google Scholar
  84. Fleischer R (1877) Untersuchgen uber das resporptions-vermogen der menschlichen haut. Erlangen 1877. Habilitationsschrift p 81.Google Scholar
  85. Flynn GL (1990) Physicochemical determinants of skin absorption. In: Gerrity TR, Henry CJ (eds) Principles of route-to-route extrapolation for risk assessment. Elsevier, New York, pp 93–127Google Scholar
  86. Foxenberg RJ, Knaak JB, McGarrigle BP, Kostyniak PJ, Olson JR (2007) Human hepatic cytochrome P450-specific metabolism of parathion and chlorpyrifos. Drug Metab Dispos 35:189–193Google Scholar
  87. Foxenberg RJ, Ellison CA, Knaak JB, Ma C, Olson JR (2011) Cytochrome P450-specific human PBPK/PD models for the organophosphorus pesticides: chlorpyrifos and parathion. Toxicology 285:57–66Google Scholar
  88. Freeman C (1982) Acute oral toxicity study in rats: FMC 54800. Study No. A83-859, FMC Corporation, Philadelphi PA.Google Scholar
  89. Freeman C (1987) Acute oral toxicity study-FMC 45806 technical: Study No. A87-2282, FMC Corporation, Philadelphia, PA.Google Scholar
  90. Freeman C (1989) Acute oral toxicity of FMC 56701 technical in rats. Study No. A89-2914, FMC Corporation, Philadelphia, PA.Google Scholar
  91. Fujikawa M, Nakao K, Shimizu R, Akamatsu M (2007) QSAR study on permeability of hydrophobic compounds with artificial membranes. Bioorg Med Chem 15:3756–3767Google Scholar
  92. Fujimoto K, Itaya N, Okuno Y, Kadota T, Yamaguchi T (1973) A new insecticidal pyrethroid ester. Agric Biol Chem 37:2681–2682Google Scholar
  93. Furnax R, Audegond L (1985a) Bioallethrin (synthetic) acute oral toxicity in rat. Study No. 84324/5635/5637, Roussel-Uclaf, Paris.Google Scholar
  94. Furnax R, Audegond L (1985b) RU 16121 acute oral toxicity in rat. Study No. 84327/5640/5641, Roussel-Uclaf, Paris.Google Scholar
  95. Gabriel D (1992) Acute oral toxicity study in rats. Study No. 92-7529A, Pyrethrin Joint Venture Chemical Specialties Manufacturing Association, Washington, DC.Google Scholar
  96. Gao R, Zhu L, Chen Z (1998) Separation of pyrethroid enantiomers of fenpropathrin and fluvalinate by chiral high performance liquid chromatography. Nongyao (Pesticides) 37(9):22–24Google Scholar
  97. Gargas ML, Burgess RJ, Voisard DE, Cason GH, Andersen ME (1989) Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicol Appl Pharmacol 98:87–99Google Scholar
  98. Gassner B, Wuthrich A, Scholtysik G, Solioz M (1997) The pyrethroids permethrin and cyhalothrin are potent inhibitors of the mitochondrial complex I. J Pharmacol Exp Ther 281:855–860Google Scholar
  99. GastroPlus Users Manual (2008) version 6.0, Simulations-Plus, Inc., Lancaster, CAGoogle Scholar
  100. Gaughan LC, Unai T, Casida JE (1977) Permethrin metabolism in rats. J Agric Food Chem 25:9–17Google Scholar
  101. Geinoz S, Guy RH, Testa B, Carrupt PA (2004) Quantitative structure-permeation relationships (QSPeRs) to predict skin permeation: a critical evaluation. Pharm Res 21:83–92Google Scholar
  102. Ghiasuddin SM, Soderlund DM (1985) Pyrethroid insecticides potent, stereospecific enhancers of mouse brain sodium channel activation. Pestic Biochem Physiol 24:200–206Google Scholar
  103. Girelli AM, Messina A, Sinibaldi M (2002) A study on the separation of synthetic pyrethroid stereoisomers by HPLC. Ann Chim 92:417–424Google Scholar
  104. Glomot R (1979) RU 25474, active material: acute oral toxicity study in the rat. American Hoechst Corporation Study No. RU-4BE-79818-19/A.Google Scholar
  105. Godin SJ, Scollon EJ, Hughes MF, Potter PM, DeVito MJ, Ross MK (2006) Species differences in the in vitro metabolism of deltamethrin and esfenvalerate: differential oxidative and hydrolytic metabolism by humans and rats. Drug Metab Dispos 34:1764–1771Google Scholar
  106. Godin SJ, Crow JA, Scollon EJ, Hughes MF, DeVito MJ, Ross MK (2007) Identification of rat and human cytochrome P450 isoforms and a rat serum esterase that metabolize the pyrethroid insecticides Deltamethrin and Esfenvalerate. Drug Metab Dispos 35:1664–1671Google Scholar
  107. Godin SJ, DeVito MJ, Hughes MF, Ross DG, Scollon EJ, Starr JM, Setzer RW, Conolly RB, Tornero-Velez R (2010) Physiologically based pharmacokinetic modeling of deltamethrin: development of a rat and human diffusion-limited model. Toxicol Sci 115:330–343Google Scholar
  108. Goksu EI, Vanegas JM, Blanchette CD, Lin W-C, Longo ML (2009) AFM for structure and dynamics of biomembranes. Biochem Biophys Acta 1788:254–266Google Scholar
  109. Goodman LS (2001) Goodman & Gilman’s the pharmacological basis of therapeutics, 10th edn. McGraw-Hill, New YorkGoogle Scholar
  110. Gray AJ, Soderlund DM (1985) Mammalian toxicology of pyrethroids. In: Hutson DH, Roberts TR (eds) Insecticides. Wiley, New York, pp 193–248Google Scholar
  111. Grosman N, Diel F (2005) Influence of pyrethroids and piperonyl butoxide on the Ca+2 –ATPase activity. Int J Immunopharmacol 5:263–270Google Scholar
  112. Guengerich FP, Martin MV (1998) Purification of cytochromes P450. Rat and human hepatic forms. Methods Mol Biol 107:35–53Google Scholar
  113. Guy RH, Hadgraft J, Bucks DA (1987) Transdermal drug delivery and cutaneous metabolism. Xenobiotica 17:325–343Google Scholar
  114. Hagiwara N, Irisawa H, Kameyama M (1988) Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells. J Physiol 395:233–253Google Scholar
  115. Hallifax D, Houston JB (2006) Binding of drugs to hepatic microsomes: comment and assessment of current prediction methodology with recommendation for improvement. Drug Metab Dispos 34:724–726Google Scholar
  116. Hamman I, Fuchs R (1981) Baythroid®, a new insecticide. Pflanzenschutz-Nachrichten Bayer 34:121–151Google Scholar
  117. Hansch C, Hoekman D, Leo A, Zhang L, Li P (1995) The expanding role of quantitative structure-activity relationships (QSAR) in toxicology. Toxicol Lett 79:45–43Google Scholar
  118. Hardt J, Angerer J (2003) Biological monitoring of workers after the application of insecticidal pyrethroids. Int Arch Occup Environ Health 76:492–498Google Scholar
  119. Harrison SM, Barry BW, Dugard PH (1984) Effects of freezing on human-skin permeability. J Pharm Pharmacol 36:261–262Google Scholar
  120. Heimann KG (1987) FCR 1272 (c.n. cyfluthrin): Study for acute oral toxicity to rats (formulation acetone and peanut oil). Bayer Corporation Agricultural Division Report No. 106805.Google Scholar
  121. Hemming H, Flodstrom S, Warngard L (1993) Enhancement of altered hepatic foci in rat-liver and inhibition of intercellular communication in-vitro by the pyrethroid insecticides fenvalerate, flucythrinate and cypermethrin. Carcinogenesis 14:2531–2535Google Scholar
  122. Henrick CA (1977) Zoecon Corp. (patent for fluvalinate development).Google Scholar
  123. Henrick CA, Garcia BA, Staal GB, Cerf DC, Anderson RJ, Gill K, Chinn HR, Labovitz JN, Leippe MM, Woo SL, Carney RL, Gordon DC, Kohn GK (1980) 2-Anilino-3-methylbutyrates and 2-(isoindolin-2-yl)-3-methylbutyrates, two novel groups of synthetic pyrethroid esters not containing a cyclopropane ring. Pestic Sci 11(2):224–241Google Scholar
  124. Hildebrand ME, McRory JE, Snutch TP, Stea A (2004) Mammalian voltage-gated calcium channels are potently blocked by the pyrethroid insecticide allethrin. J Pharmacol Exp Ther 308:805–813Google Scholar
  125. Hood SR, Shah G, Jones P (1998) Ch 24, Expression of cytochromes P450 in a Baculovirus system. In: Phillips IR, Shepard EA (eds) Methods in molecular biology: CYP protocols. Humana, Totowa, NJ, pp 203–218Google Scholar
  126. Horber JKH, Mosbacher J, Haberle W, Ruppersberg JP, Sakmann B (1995) A look at membrane patches with a scanning force microscope. Biophys J 68:1687–1693Google Scholar
  127. Hosokawa M, Maki T, Satoh T (1987) Muliplicity and regulation of hepatic microsomal carboxylesterases in rats. Mol Pharmacol 31:579–584Google Scholar
  128. Hosokawa M, Maki T, Satoh T (1990) Characterization of molecular species of liver microsomal carboxylesterases of several animal species and humans. Arch Biophys 277:219–227Google Scholar
  129. Hotchkiss SAM, Miller JM, Caldwell J (1992) Percutaneous absorption of benzyl acetate through rat skin in vitro. 2. Effect of vehicle and occlusion. Food Chem Toxicol 30:145–153Google Scholar
  130. Houston JB (1994) Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem Pharmacol 47:1469–1479Google Scholar
  131. Huang T, Kuang C, Zhou J, Gou D (1991) Chiral separation of water soluble. BETA-Lactam Enanatiomers on BETA-Cyclodextrin bonded stationary phase. Fenxi Huaxue 16:687–689Google Scholar
  132. Huckle KR, Chipman JK, Hutson DH, Miliburn P (1981a) Metabolism of 3-phenoxybenzoic acid and the enterohepatorenal disposition of its metabolites in the rat. Drug Metab Dispos 9:360–368Google Scholar
  133. Huckle KR, Hutson DH, Millburn P (1981b) Species differences in the metabolism of 3-phenoxybenzoic acid. Drug Metab Dispos 9:352–359Google Scholar
  134. Huckle KR, Hutson DH, Millburn P (1984) Metabolism of 3-phenoxybenzoic acid in isolated rat hepatocytes and renal tubule fragments. Drug Metab Dispos 12:264–265Google Scholar
  135. Huff RK (1978) Halogenated esters of cyclopropane acids, their preparation, composition and use as pesticides. Eur Pat 0010879 ICI.Google Scholar
  136. Hutson DH, Logan CJ (1986) The metabolic fate in rats of the pyrethroid insecticide WL85871, a mixture of two isomers of cypermethrin. Pestic Sci 17:548–558Google Scholar
  137. IARC (1991) Occupational exposures in insecticide application and some pesticides. IARC, LyonGoogle Scholar
  138. Inoue S, Howgate EM, Rowland-Yeo K, Shimada T, Yamazaki H, Tucker GT, Rostami-Hodjegan A (2006) Prediction of in vivo drug clearance from in vitro data. II: Potential inter-ethnic differences. Xenobiotica 36:499–513Google Scholar
  139. Irvine JD, Takahashi L, Lockhart K, Cheong J, Tolan JW, Selick HE, Grove JR (1999) MDCK (Madin-Darby Canine Kidney) cells: a tool for membrane permeability screening. J Pharm Sci 88:28–33Google Scholar
  140. Iwatsubo T, Hirota N, Ooie T, Suzuki H, Chiba K, Ishizaki T, Green CE, Tyson CA, Sugiyama Y (1997) Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data. Pharmacol Ther 73:147–171Google Scholar
  141. Izumi T, Kaneko H, Matsuo M, Miyamoto J (1984) Comparative metabolism of the six stereoisomers of phenothrin in rats and mice. J Pestic Sci 9:259–267Google Scholar
  142. Jarabek A (2002) External Review Draft NCEA-1-0503, Office of Research and Development. US Environmental Protection Agency, Washington, DCGoogle Scholar
  143. Jepson GW, Hoover DK, Black RK, McCafferty JD, Mahle DA, Gearhart JM (1992) Partition coefficient determination for nonvolatile and intermediate volatility chemicals in biological tissues. Toxicology 12:262Google Scholar
  144. Jepson GW, Hoover DK, Black RK, McCafferty JD, Mahle DA, Gearhart JM (1994) A partition coefficient determination methods for non-volatile chemicals in biological issues. Fundam Appl Toxicol 22:519–524Google Scholar
  145. Johnson PL (2007) Synthesis of (S)-cyano (3-phenoxyphenyl) methyl (1R, 3R)-3-[(1Z)-2-chloro-3, 3, 3-trifluoro-1-propenyl)-2, 2-dimethylcyclopropanecarboxylate-1-14C. J Label Compd Radiopharm 50:47–53Google Scholar
  146. Jutsum AR, Gordon RF, Ruscoe CNE (1986) In: Proc. 1986 Brit Crop Prot Conf Pests and Diseases, BCPC, Croydon, pp 97–106.Google Scholar
  147. Kakko I, Toimela T, Tahti H (2003) The synaptosomal membrane bound ATPase as a target for the neurotoxic effects of pyrethroids, permethrin and cypermethrin. Chemosphere 51:475–480Google Scholar
  148. Kaneko H (2010) Chapter 76, Pyrethroid chemistry and metabolism. In: Krieger R (ed) Hayes’ handbook of pesticide toxicology, 3rd edn. Academic, San Diego, CAGoogle Scholar
  149. Kaneko H, Miyamoto J (2001) Pyrethroid chemistry and metabolism, chapter 58. In: Krieger R (ed) Hayes handbook of pesticide toxicology, 2nd edn. Academic, San Diego, CAGoogle Scholar
  150. Kaneko H, Ohkawa H, Miyamoto J (1981a) Adsorption and metabolism of dermally applied phenothrin in rats. Nippon Noyaku Gakkaishi 6:169–182Google Scholar
  151. Kaneko H, Ohkawa H, Miyamoto J (1981b) Comparative metabolism of fenvalerate and the [2S, αS]-isomer in rats and mice. Nippon Noyaku Gakkaishi 6:317–326Google Scholar
  152. Kaneko H, Ohkawa H, Miyamoto J (1981c) Metabolism of tetramethrin isomers in rats. Nippon Noyaku Gakkaishi 6:425–435Google Scholar
  153. Kaneko H, Matsuo M, Miyamoto J (1984) Comparative metabolism of stereoisomers of cyphenothrin and phenothrin isomers in rats. Nippon Noyaku Gakkaishi 9:237–247Google Scholar
  154. Kaneko H, Shiba K, Yoshitake A, Miyamoto J (1987) Metabolism of fenpropathrin (S-3206) in rats. Nippon Noyaku Gakkaishi 12:385–395Google Scholar
  155. Kansy M, Senner F, Gubernator K (1998) Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. J Med Chem 41(7):1007–1010Google Scholar
  156. Kato T, Ueda K, Fujimoto K (1965) New insecticidally active chrysanthemate. Agric Biol Chem 28:914–915Google Scholar
  157. Katsuda Y (1975) Sumitomo Chemical Co, LTD. (patent for fluvalinate development).Google Scholar
  158. Katsuda Y (1999) Development of and future prospects for pyrethroid chemistry. Pestic Sci 55:775–782Google Scholar
  159. Khambay BPS (2002) Pyrethroid insecticides. Royal Society of Chemistry (UK). Pestic Outlook 49–54.Google Scholar
  160. Killeen JCJ (1975) Acute oral toxicity study in rats with FMC 33297. FMC Corp, Philadelphia, PAGoogle Scholar
  161. Klopman G, Rosenkranz HS (1995) Toxicity estimation by chemical substructure analysis: the TOX II program. Toxicol Lett 79:145–155Google Scholar
  162. Knaak JB, Iwata Y, Maddy KT (1989) The worker hazard posed by reentry into pesticide-treated foliage: development of safe reentry times, with emphasis on chlorthiophos and carbosulfan, Ch 24. In: Paustenbach D (ed) The risk assessment of environmental hazards: a textbook of case studies. Wiley, New York, pp 797–842Google Scholar
  163. Knaak JB, Wagner B, Boutchyard H Jr, Smith LW, Jones T, Wang RH (1993) Computerization of toxicological data by government agencies, chemical, and information industries, Ch 19. In: Jolley RL, Wang RGM (eds) Effective and safe waste management; interfacing sciences and engineering with monitoring and risk analysis. Lewis, Boca Raton, FL, pp 227–264Google Scholar
  164. Knaak JB, Leung H-W, Stott WT, Busch J, Bilsky J (1997) Toxicology of mono-, di-, and triethanolamine. Rev Environ Contam Toxicol 149:1–86Google Scholar
  165. Knaak JB, Dary C, Patterson GT, Blancato J (2002) The worker hazard posed by reentry into pesticide-treated foliage: reassessment of reentry levels/intervals using foliar residue transfer-percutaneous absorption PBPK/PD models, with emphasis on isofenphos and parathion. In: Paustenbach D (ed) Human and ecological risk assessment: theory and practice. Wiley, New York, pp 673–731Google Scholar
  166. Knaak JB, Dary CC, Power F, Thompson CB, Blancato JN (2004) Physicochemical and biological data for the development of predictive organophosphorus pesticides QSARs and PBPK/PD models for human risk assessment. Crit Rev Toxicol 34:143–207Google Scholar
  167. Knaak JB, Dary CC, Okino MS, Power FW, Zhang X, Thompson CB, Tornero-Velez R, Blancato JN (2008) Parameters for carbamate pesticide QSAR and PBPK/PD models for human risk assessment. Rev Environ Contam Toxicol 193:53–212Google Scholar
  168. Kuo JK (1985) Phospholipids and cellular regulation. CRC, Boca Raton, FLGoogle Scholar
  169. Kurihara N, Miyamoto J, Paulson GD, Zeeh B, Skidmore MW, Hollingsworth RM, Kuiper HA (1997a) Chirality in synthetic agrochemicals: bioactivity and safety considerations. Pure Appl Chem 69:1335–1348Google Scholar
  170. Kurihara N, Miyamoto J, Paulson GD, Zeeh B, Skidmore MW, Hollingsworth RM, Kipper HA (1997b) Chirality in synthetic agrochemicals: bioactivity and safety consideration. Pure Appl Chem 69:2007–2026Google Scholar
  171. Kutter JP, Class TJ (1992) Diastereoselective and enantioselective chromatography of the pyrethroid insecticides allethrin and cypermethrin. Chromatograhia 33:103–112Google Scholar
  172. LaForge FB, Haller HL (1936) Constituents of pyrethrum flowers. VI. The structure of pyrethrolone. J Am Chem Soc 58:1777–1780Google Scholar
  173. LaForge FB, Soloway SB (1947) Structure of dihydrocinerolone. J Am Chem Soc 69:186Google Scholar
  174. Lau YY, Wu C-Y, Okochi H, Benet LZ (2003) Ex situ inhibition of hepatic uptake and efflux significantly changes metabolism: hepatic enzyme-transporter interplay. J Pharmacol Exp Ther 308:1040–1045Google Scholar
  175. Lawrence LJ, Gee KW, Yamamura HI (1985) Interactions of pyrethroid insecticides with chloride ionophore-associated binding sites. Neurotoxicology 6:87–98Google Scholar
  176. Lee W, Kim B-H (1998) Liquid chromatographic resolution of pyrethroic acids and their esters on chiral stationary phases. J High Resol Chromatogr 21:189–192Google Scholar
  177. Leng G, Leng A, Kuhn K-H, Lewalter J, Pauluhn J (1997) Human dose-excretion studies with the pyrethroid insecticide cyfluthrin: urinary metabolite profile following inhalation. Xenobiotica 27:1273–1293Google Scholar
  178. Li Z-Y, Zhang Z-C, Zhou Q-L, Wang Q-M, Gao R-Y, Wang Q-S (2003) Stereo and enantioselective determination of pesticides in soil by using achiral and chiral liquid chromatography in combination with matrix solid-phase dispersion. J AOAC Int 86(3):521–528Google Scholar
  179. Li Z-Y, Zhang Z-C, Zhang L, Leng L (2006) Chiral separation of pyrethroids pesticides and fenvaleric acid. Fenxi Shiyanshi (Chin J Anal Lab) 25(11):11–14Google Scholar
  180. Li Z, Zhang Z, Zhang L, Leng L (2009) Isomer- and enantioselective degradation and chiral stability of fenpropathrin and fenvalerate in soils. Chemosphere 76:509–516Google Scholar
  181. Liang R, Fei Y-J, Prasad PD, Ramamoorthy S, Han H, Yang-Feng TL, Hediger MA, Ganapathy V, Leibach FH (1995) Human intestinal H+/peptide cotransporter: cloning, functional expression, and chromosomal localization. J Biol Chem 270:6456–6463Google Scholar
  182. Lin JH, Yamazaki M (2003) Role of P-glycoprotein in pharmacokinetics: clinical implications. Clin Pharmacokinet 42:59–98Google Scholar
  183. Lipscomb JC, Fisher JW, Confer PD, Byczkowski JZ (1998) In vitro to in vivo extrapolation for trichloroethylene metabolism in humans. Toxicol Appl Pharmacol 152:376–387Google Scholar
  184. Liu HX, Yao XJ, Zhang RS, Liu MC, Hu ZD, Fan BT (2005a) Prediction of the tissue/blood partition coefficients of organic compounds based on the molecular structure using least-squares support vector machines. J Comput Aided Mol Des 19:499–508Google Scholar
  185. Liu W, Gan J, Schlenk D, Jury WA (2005b) Enantioselectivity in environmental safety of current chiral insecticides. Proc Natl Acad Sci USA 102(3):701–706Google Scholar
  186. Liu W, Gan JJ, Qin S (2005c) Separation and aquatic toxicity of enantiomers of synthetic pyrethroid insecticides. Chirality 17:S127–S133Google Scholar
  187. Liu W, Gan J, Lee S, Werner I (2005d) Isomer selectivity in aquatic toxicity and biodegradation of bifenthrin and permethrin. Environ Toxicol Chem 24(8):1861–1866Google Scholar
  188. Lu AYH, West SB (1980) Multiplicity of mammalian microsomal cytochrome P450. Pharmacol Rev 31:277–291Google Scholar
  189. Maibach HI, Feldmann RJ, Milby TH, Serat WF (1971) Regional variation in percutaneous penetration in man. Arch Environ Health 23:208–211Google Scholar
  190. Mancini F, Fiori J, Bertucci C, Cavrini V, Bragieri M, Zanotti MC, Liverani A, Borzatta V, Andrisano V (2004) Stereoselective determination of allethrin by two-dimensional achiral/chiral liquid chromatography with ultraviolet/circular dichroism detection. J Chromatogr A 1046:67–73Google Scholar
  191. Martel J (1976) Roussel UCLAF (patent, tralomethrin development).Google Scholar
  192. Matsuo T, Itaya N, Mizutani T, Ohno N, Fujimoto K, Okuno Y, Yoshioka H (1976) 3-phenoxy-a-cyanobenzyl esters, the most potent synthetic pyrethroids. Agric Biol Chem 40:247–249Google Scholar
  193. Mattie DR, Bates GD, Jepson GW, Fisher JW, McDougal JN (1994) Determination of skin: air partition coefficients for volatile chemicals: experimental method and applications. Toxicol Appl Pharmacol 22:51–57Google Scholar
  194. McGregor DB (1999) Permethrin Joint Meeting, FAO Panel of Experts on Pesticide Residues in Food and the Environment, and WHO Core Assessment Group, Rome.Google Scholar
  195. Meylan WM, Howard PH (1994a) Upgrade of PCGEMS water solubility estimation method (draft). US Environmental Protection Agency, Office of Pollution Prevention and Toxics, Washington, DCGoogle Scholar
  196. Meylan WM, Howard PH (1994b) Validation of water solubility estimation methods using log Kow for application in PCGEMS & EPI. Final report, U.S. Environmental Protection Agency, Office of Pollution Prevention and Toxics, Washington, DC.Google Scholar
  197. Mirfazaelian A, Kim K-B, Anand SS, Kim HJ, Tornero-Velez R, Bruckner JV, Fisher JW (2006) Development of a physiologically based pharmacokinetic model for deltamethrin in the adult male Sprague-Dawley rat. Toxicol Sci 93:432–442Google Scholar
  198. Miyamoto J (1976) Degradation, metabolism and toxicity of synthetic pyrethroids. Environ Health Perspect 14:15–28Google Scholar
  199. Miyamoto J, Nishida T, Ueda K (1971) Metabolic fate of resmethrin, 5-benzyl-3-furylmethyl dl-trans chrysanthemate in the rat. Pestic Biochem Physiol 1:293–306Google Scholar
  200. Miyamoto J, Suzuki T, Nakae C (1974) Metabolism of phenothrin (3-phenoxybenzyl d-trans-chrysanthemumate) in mammals. Pestic Biochem Physiol 4:438–450Google Scholar
  201. Moss GP, Derden JC, Patel H, Cronin MT (2002) Quantitative structure-permeability relationships (QSPRs) for percutaneous absorption. Toxicol In Vitro 16:299–317Google Scholar
  202. Mugeng J, Soderlund DM (1982) Liquid chromatographic determination and resolution of the enantiomers of the acid moieties of pyrethroid insecticides as their (-)-1-(1-phenyl)ethylamide derivatives. J Chromatogr A 248(1):143–149Google Scholar
  203. Myer JR (1989) Acute oral toxicity study of deltamethrin in rats. Hoechst-Roussel Agri-Vet Company Study No. 327-122.Google Scholar
  204. Nakamura Y, Sugihara K, Sone T, Isobe M, Ohta S, Kitamura S (2007) The in vitro metabolism of a pyrethroid insecticide, permethrin, and its hydrolysis products in rats. Toxicology 235:176–184Google Scholar
  205. Narahashi T (1971) Mode of action of pyrethroids. Bull World Health Organ 44:337–345Google Scholar
  206. Nardini M, Dijkstra BW (1999) α/β Hydrolase fold enzymes: the family keeps growing. Curr Opin Struct Biol 9:732–737Google Scholar
  207. Naumann K (1998) Research into fluorinated pyrethroid alcohols-an episode in the history of pyrethroid discovery. Pestic Sci 52:3–20Google Scholar
  208. Nicoli S, Santi P (2007) Suitability of excised rabbit ear skin – fresh and frozen – for evaluation Transdermal permeation of estradiol. Drug Deliv 14:195–199Google Scholar
  209. Nigg HN, Knaak JB (2000) Blood cholinesterases as human biomarkers of organophosphorus pesticide exposure. Rev Environ Contam Toxicol 163:29–112Google Scholar
  210. Nikolelis DP, Brennan JD, Brown S, McGibbon G, Krull UJ (1991) Ion permeability through bilayer lipid membranes for biosensor development: control by chemical modification of interfacial regions between phase domains. Analyst 116:1221–1226Google Scholar
  211. Nishizawa Y (1971) Development of new synthetic pyrethroids. Bull World Health Organ 44:325–336Google Scholar
  212. Nong A, Tan Y-M, Krolski ME, Wang J, Lunchick C, Conolly RB, Clewell HJ III (2008) Bayesian calibration of a physiologically-based pharmacokinetic/pharmacodynamic model of carbaryl cholinesterase inhibition. J Toxicol Environ Health A 71:1363–1381Google Scholar
  213. O’Reilly AO, Khanbay BPS, Williamson MS, Field LM, Wallace BS, Davies TGE (2006) Modeling insecticide-binding sites in the voltage-gated sodium channel. Biochem J 396:255–263Google Scholar
  214. Obach RS (1996) The importance of nonspecific binding in in vitro matrices, its impact on enzyme kinetic studies of drug metabolism and implications for in vitro-in vivo correlations. Drug Metab Dispos 24:1047–1049Google Scholar
  215. Obach RS (1997) Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol. Drug Metab Dispos 25:1359–1369Google Scholar
  216. Obach RS (1999) The prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of the in vitro half-life approach and non-specific binding to microsomes. Drug Metab Dispos 27:1350–1359Google Scholar
  217. Ohkawa H, Kaneko H, Tsuji H, Miyamoto J (1979) Metabolism of fenvalerate (Sumicidin) in rats. J Pestic Sci (J Nippon Noyaku Gakkaishi) 4:143–155Google Scholar
  218. Ohno N, Fujimoto K, Okuno Y, Mizutani T, Hirano M, Yoshioka H (1974) A new class of pyrethroidal insecticides: α-substituted phenylacetic acid esters. Agric Biol Chem 38:881–883Google Scholar
  219. Oi N (2005) Development of practical chiral stationary phases for chromatography and their applications. Chromatography 26(1):1–5Google Scholar
  220. Oi N, Horiba M, Kitahara H (1981) Gas chromatographic separation of optical isomers of chrysanthemic acid on an optically active stationary phase. Agric Biol Chem 45(6):1509–1510Google Scholar
  221. Oi N, Kitahara H, Kira R (1990) Enantiomer separation of pyrethroid insecticides by high-performance liquid chromatography with chiral stationary phases. J Chromatogr A 515:441–450Google Scholar
  222. Oi N, Kitahara H, Aoki F, Kisu N (1995) Direct separation of carboxylic acid enantiomers by high-performance liquid chromatography with amide and urea derivatives bonded to silica gel as chiral stationary phases. J Chromatogr A 689(2):195–201Google Scholar
  223. Oi N, Kitahara H, Matsushita Y, Kisu N (1996) Enantiomer separation by gas and high-performance liquid chromatography with tripeptide derivatives as chiral stationary phases. J Chromatogr A 722(1–2):229–232Google Scholar
  224. Omura T, Sato (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239:2370–2378Google Scholar
  225. Paine MF, Khalighi M, Fisher JM, Shen DD, Kunze KOL, Cl M, Perkins JD, Thummel KE (1997) Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. J Pharmacol Exp Ther 283:1552–1562Google Scholar
  226. Papadopoulou-Mourkidou E (1985) Direct analysis of fenvalerate isomers by liquid chromatography. Application to formulation and residue analysis of fenvalerate. Chromatographia 20(6):376–378Google Scholar
  227. Payne MP, Kenny LC (2002) Comparison of models for the estimation of biological partition coefficients. J Toxicol Environ Health A 65:897–931Google Scholar
  228. PMRA (Canada Pest Management Regulatory Agency) (2005) Report PRDD#2005-02 (imiprothrin), www.pmra-arla.gc.ca/english/pdf/prdd/prdd2005-02-e.pdf, Aug 8 2005.
  229. Plummer EL, Cardis AB, Martinez AJ, Van Saun WA, Palmere RM, Pincus DS, Stewart RR (1983) Pyrethroid insecticides derived from substituted biphenyl-3-methods. Pestic Sci 14:560–570Google Scholar
  230. Porcelli C, Roncaglioni A, Chana A, Boriani E, Benfenati A (2007) A protocol for quantitative structure, activity relationship (QSAR) for regulatory purposes: the example of DEMETRA. In Environmental fate and ecological effects of pesticides, symposium pesticide chemistry, 13th, Placenza, Italy, Sept. 3–6, 2007, pp 669–674.Google Scholar
  231. Potts RO, Guy RH (1992) Predicting skin permeability. Pharm Res 9:663–669Google Scholar
  232. Potts RO, Guy RH (1995) A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity. Pharm Res 12:1628–1633Google Scholar
  233. Poulin P, Theil F-P (2000) A priori prediction of tissue: plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery. J Pharm Sci 89:16–35Google Scholar
  234. Poulin P, Theil F-P (2002a) Prediction of pharmacokinetics prior to in vivo studies. I. Mechanism-based prediction of volume of distribution. J Pharm Sci 91:129–156Google Scholar
  235. Poulin P, Theil F-P (2002b) Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically-based pharmacokinetic models of drug disposition. J Pharm Sci 91:1358–1370Google Scholar
  236. Prout M, Howard E (1985b) PP993: excretion and tissue distribution of a single oral dose (10 mg/kg) in the rat. Syngenta unpublished report, no. CTL/P/1256, UK.Google Scholar
  237. Prout M, Howard E, Soames A (1985a) PP993: Absorption, excretion and tissue distribution of a single oral dose (1 mg/kg) in the rat. Syngenta unpublished report, no. CTL/P/1064, UK.Google Scholar
  238. Prout M, Gibson N, Howard E (1986) PP993: Biotransformation in the rat. Syngenta unpublished report, no. CTL/P/1295, UK.Google Scholar
  239. Casida JE (ed) (1973) Pyrethrum: the natural insecticide. Academic, New YorkGoogle Scholar
  240. Quistad GB, Staiger LE, Jamieson GC, Schooley DA (1983) Fluvalinate metabolism by rats. J Agric Food Chem 31:589–596Google Scholar
  241. Rand G (1983) Acute oral toxicity-cypermethrin technical. FMC Corporation Study No. A82-727.Google Scholar
  242. Rao RN, Shankaraiah B, Sunder MS (2004) Separation and determination of diastereomers of γ-Cyhalothrin by normal phase-liquid chromatography using a CN column. Anal Sci 20:1745–1748Google Scholar
  243. Ray DE, Fry JR (2006) A reassessment of the neurotoxicity of pyrethroids insecticides. Pharmacol Ther 111:174–193Google Scholar
  244. Ray DE, Sutharsan S, Forshaw PJ (1997) Actions of pyrethroid insecticides on voltage-gated chloride channels in neuroblastoma cells. Neurotoxicology 18:755–760Google Scholar
  245. Reifenrath WG, Kamppainen BW (1991) Skin storage conditions. In: Bronaugh R, Maibach H (eds) In vitro percutaneous absorption: principles, fundamentals and applications. CRC, Boca Raton, pp 115–125Google Scholar
  246. Reifenrath WG, Ross JH, Driver JH (2011) Experimental methods for determining permethrin dermal absorption. Submitted for review and publication. J Toxicol Environ Health A 74: 325–335.Google Scholar
  247. Rekling JC, Theophilidis GN (1995) Effects of the pyrethroid insecticide, deltamethrin, on respiratory modulated hypoglossal moto-neurons in a brain stem slice from newborn mice. Neurosci Lett 198:189–192Google Scholar
  248. Riddles PW, Richards LJ, Bowles MR, Pond SM (1991) Cloning and analysis of a cDNA encoding a human liver carboxylesterase. Gene (Amst) 108:389–392Google Scholar
  249. Riviere JE, Monteiro-Riviere NA (1991) The isolated perfused porcine skin flap as an in vitro model for percutaneous absorption and cutaneous toxicology. Crit Rev Toxicol 21:329–344Google Scholar
  250. Riviere JE, Bowman KF, Monteiro-Riviere NA, Dix LP, Carver MP (1986) The isolated perfused porcine skin flap (IPPSF). I. A novel in vitro model for percutaneous absorption and cutaneous toxicology studies. Fund Appl Toxicol 7:444–453Google Scholar
  251. Robey RW, Lin B, Qui J, Chan LL, Bates SE (2010) Rapid detection of ABC transporter interaction: potential utility in pharmacology. J Pharmacol Toxicol Methods 63:217–222Google Scholar
  252. Rodgers T, Rowland M (2006) Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutral and zwitterions. J Pharm Sci 95:1238–1257Google Scholar
  253. Rodgers T, Rowland M (2007) Mechanistic approaches to volume of distribution predictions: understanding the processes. Pharm Res 24:918–933Google Scholar
  254. Rodgers T, Leahy D, Rowland M (2005) Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases. J Pharm Sci 94:1259–1276Google Scholar
  255. Rodgers T, Leahy D, Rowland M (2007) (ERRATA) Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate to strong bases. J Pharm Sci 96:1259–1276, J Pharm Sci 96: 3151–3152Google Scholar
  256. Rodrigues AD (1999) Integrated cytochrome P450 reaction phenotyping: attempting to bridge the gap between cDNA-expressed cytochrome P450 and native human liver microsomes. Biochem Pharmacol 57:465–480Google Scholar
  257. Ross MK, Borazjani A, Edwards CC, Potter PM (2006) Hydrolytic metabolism of pyrethroids by human and other mammalian carboxylesterases. Biochem Pharmacol 71:657–669Google Scholar
  258. Ruzo LO, Casida JE (1977) Metabolism and toxicology of pyrethroids with dihalovinyl substituents. Environ Health Perspect 21:285–292Google Scholar
  259. Ruzo LO, Casida JE (1981) Pyrethroid photochemistry: (S)-a-cyano-3-phenoxybenzyl cis-(1R,3R,1′R or S)-3-(1′,2′-dibromo-2′,2′-dihaloethyl)-2,2-dimethylcyclopropanecarboxylates. J Agric Food Chem 29:702–706Google Scholar
  260. Ruzo LO, Unai T, Casida JE (1978) Decamethrin metabolism in rats. J Agric Food Chem 26:918–925Google Scholar
  261. Ruzo LO, Engel JL, Casida JE (1979) Decamethrin metabolites from oxidative, hydrolytic, and conjugative reactions in mice. J Agric Food Chem 27:725–731Google Scholar
  262. Saiakhov RD, Stefan LR, Klopman G (2000) Multiple computer-automated structure evaluation model of the plasma protein binding affinity of diverse drugs. Perspect Drug Discov Des 19:133–155Google Scholar
  263. Sanchez FG, Diaz AN, Pareja AG (1996) Enantiomeric resolution of pyrethroids by high-performance liquid chromatography with diode-laser polarimetric detection. J Chromatogr A 754:97–102Google Scholar
  264. Satoh T, Hosokawa M (1998) The mammalian carboxylesterases: from molecules to functions. Annu Rev Pharmacol Toxicol 38:257–288Google Scholar
  265. Satoh T, Hosokawa M (2010) Carboxylesterases: structure, function and polymorphism in mammals. J Pestic Sci 35:218–228Google Scholar
  266. Scheuplein RJ, Blank IH (1971) Permeability of the skin. Physiol Rev 51:702–747Google Scholar
  267. Schwenkenbecker A (1904) Das absorptions verniogen der haut. Arch Anat Physiol 121–165.Google Scholar
  268. Schwer H, Langmann T, Daig R, Becker A, Aslanidis C, Schmitz G (1997) Molecular cloning and characterization of a novel putative carboxylesterase, present in human intestine and liver. Biochem Biophys Res Commun 233:117–120Google Scholar
  269. Scollon EJ, Starr JM, Godin SJ, DeVitro MJ, Hughes MF (2009) In vitro metabolism of pyrethroid pesticides by rat and human hepatic microsomes and cytochrome P450 isoforms. DMD 37:221–228Google Scholar
  270. Scott RC, Ramsay JD (1987) Comparison of the in vivo and in vitro percutaneous absorption of a lipophilic molecule (cypermethrin, a pyrethroid insecticide). J Invest Dermatol 89:142–146Google Scholar
  271. Serat WF (1973) Calculation of a safe reentry time into an orchard treated with a pesticide chemical which produces a measurable physiological response. Arch Environ Contam Toxicol 1:170–181Google Scholar
  272. Serat WF, Bailey JB (1974) Estimating the relative toxicologic potential of each pesticide in mixture of residues on foliage. Bull Environ Contam Toxicol 12:682–686Google Scholar
  273. Serat WF, Mengle DC, Anderson HP, Kahn E (1975) On the estimation of worker entry intervals into pesticide treated fields with and without the exposure of human subjects. Bull Environ Contam Toxicol 13:506–512Google Scholar
  274. Shafer TJ, Meyer DA, Crofton KM (2005) Developmental neurotoxicity of pyrethroid insecticides: critical review and future research needs. Environ Health Perspect 113:123–135Google Scholar
  275. Sidon EW, Moody RP, Franklin CA (1988) Percutaneous absorption of cis- and trans-permethrin in rhesus monkeys and rats: Anatomic site and interspecies variation. J Toxicol Environ Health A 23:207–216Google Scholar
  276. Smith PA, Thompson MJ, Edwards JW (2002) Estimating occupational exposure to the pyrethroid termiticide bifenthrin by measuring metabolites in urine. J Chromatogr B 778:113–120Google Scholar
  277. Soderlund DM, Clark JM, Sheets LP, Mullin LS, Piccirillo VJ, Sargent D, Stevens JT, Weiner ML (2002) Mechanisms of pyrethroid neurotoxicity: implications for cumulative risk assessment. Toxicology 171:3–59Google Scholar
  278. Song J-H, Narahashi T (1996) Modulation of sodium channels of rat cerebellar Purkinje neurons by the pyrethroid tetramethrin. J Pharmacol Exp Ther 277:445–453Google Scholar
  279. Sorich MJ, McKinnon RA, Miners JO, Smith PA (2006) The importance of local chemical structure for chemical metabolism by human uridine 5′-diphosphate-gluronyltransferase. J Chem Inf Model 46:2692–2697Google Scholar
  280. Southwood J (1985a) PP321: Acute oral toxicity studies. Zeneca Agricultural Products Laboratory Project No. CTL/P/1102, Wilmington, DE.Google Scholar
  281. Southwood J (1985b) PP993: Acute oral toxicity, acute intraperitoneal toxicity, and acute dermal toxicity studies. Zeneca Agricultural Products Laboratory Project No. CTL/P/986, Wilmington, DE.Google Scholar
  282. Staiger LE, Quistad GB (1984) Metabolism of [benzyl-U-ring-14C] fluvalinate by rats. J Agric Food Chem 32:1130–1133Google Scholar
  283. Stephens RH, O’Neill CA, Warhurst A, Carlson GL, Rowland M, Warhurst G (2001) Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia. J Pharmacol Exp Ther 296:584–591Google Scholar
  284. Stok JE, Huang H, Jones PD, Wheelock CE, Morisseau C, Hammock BD (2004) Identification, expression, and purification of a pyrethroid-hydrolyzing carboxylesterase from mouse liver microsomes. J Biol Chem 279:29863–29869Google Scholar
  285. Sudhahar CG, Haney RM, Xue Y, Stahelin RV (2008) Cellular membranes and lipid-binding domains as attractive targets for drug development. Curr Drug Targets 9:603–613Google Scholar
  286. Suzuki T, Miyamoto J (1974) Metabolism of tetramethrin in houseflies and rats in vitro. Pestic Biochem Physiol 4:86–97Google Scholar
  287. Suzuki T, Ohno N, Miyamoto J (1976) New metabolites of (+)-cis-fenothrin, 3 phenoxybenzyl (+)-cis-chrysanthemumate, in rats. J Pestic Sci 1:151–152Google Scholar
  288. Symington SB, Frisbie RK, Clark JM (2008) Characterization of 11 commercial pyrethroids on the functional attributes of rat brain synaptosomes. Pestic Biochem Physiol 92:61–69Google Scholar
  289. Tamai I, Takanaga H, Maeda H, Sai Y, Ogihara T, Higashida H, Tsuji A (1995) Participation of a proton-cotransporter, MCT1, in the intestinal transport of monocarboxylic acid. Biochem Biophys Res Commun 214:482–489Google Scholar
  290. Tan HL, Bezzina CR, Smits JPP, Verkerk AO, Wilde AAM (2003) Genetic control of sodium channel function. Cardiovasc Res 57:961–973Google Scholar
  291. Tan J, Liu Z, Wang R, Huang ZY, Chen AC, Gurevitz M, Dong K (2005) Identification of amino acid residues in the insect sodium channel critical for pyrethroid binding. Mol Pharmacol 67:513–522Google Scholar
  292. Tan X, Hou S, Wang M (2007) Enantioselective and diastereoselective separation of synthetic pyrethroid insecticides on a novel chiral stationary phase by high-performance liquid chromatography. Chirality 19:574–580Google Scholar
  293. Tatebayashi H, Narahashi T (1994) Differential mechanism of action of the pyrethroid tetramethrin on tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels. J Pharmacol Exp Ther 270:595–603Google Scholar
  294. Tateno C, Ito S, Tanaka M, Yoshitake A (1993) Effects of pyrethroid insecticides on gap junctional intercellular communications in Balb/c3T3 cells by dye-transfer assay. Cell Biol Toxicol 9:215–221Google Scholar
  295. Timchalk C, Nolan RJ, Mendrala AL, Dittenber DA, Brzak KA, Mattsson JL (2002) A physiologically-based pharmacokinetic and pharmacodynamic (PBPK/PD) model for the organophosphate insecticide chlorpyrifos in rats and humans. Toxicol Sci 66:34–53Google Scholar
  296. Tomigahara Y, Mori M, Shiba K, Isobe N, Kaneko H, Nakatsuka I, Yamada H (1994a) Metabolism of tetramethrin isomers in rat. I. Identification of a sulfonic acid type of conjugate and reduced metabolites. Xenobiotica 24:473–484Google Scholar
  297. Tomigahara Y, Mori M, Shiba K, Isobe N, Kaneko H, Nakatsuka I, Yamada H (1994b) Metabolism of tetramethrin isomers in rat. II. Identification and quantification of metabolites. Xenobiotica 24:1205–1214Google Scholar
  298. Tomigahara Y, Shiba K, Isobe N, Kaneko H, Nakatsuke I, Yamada H (1994c) Identification of two new types of S-linked conjugates of Etoc in rat. Xenobiotica 24:839–852Google Scholar
  299. Tomigahara Y, Onogi M, Miki M, Yanagi K, Shiba K, Kaneko H, Nakatsuka I, Yamada H (1996) Metabolism of tetramethrin isomers in rat. III. Stereochemistry of reduced metabolites. Xenobiotica 26:201–210Google Scholar
  300. Tomigahara Y, Onogi M, Saito K, Kaneko H, Nakatsuka I, Yamane S (1997) Metabolism of tetramethrin in rat. IV. Tissues responsible for formation of reduced and hydrated metabolites. Xenobiotica 27(9):961–971Google Scholar
  301. Tornero-Velez R, Mirfazaelian A, Kim KB, Anand SS, Kim HJ, Haines WT, Bruckner JV, Fisher JW (2010) Evaluation of deltamethrin kinetics and dosimetry in the maturing rat using PBPK model. Toxicol Appl Pharmacol 244:208–217Google Scholar
  302. Tsuji T, Kaneda N, Kado K, Yokokura T, Yoshimoto T, Tsuru D (1991) CPT-11 converting enzyme from rat serum: purification and some properties. J Pharmacobiodyn 14:341–349Google Scholar
  303. Tubic M, Wagner D, Spahn-Langguth H, Bolger MB, Langguth P (2006) In silico modeling of non-linear drug absorption for the P-gp substrate Talinolol and of consequences for the resulting pharmacodynamic effect. Pharm Res 23:1712–1720Google Scholar
  304. Tullman RH (1987) Data Evaluation Report No. 005731. U.S. Environmental Protection Agency, Washington, DCGoogle Scholar
  305. Ueda K, Gaughan LC, Casida JE (1975) Metabolism of (+)-trans- and (+)-cis -Resmethrin in rats. J Agric Food Chem 23:106–115Google Scholar
  306. Ueda K, Cornwell MM, Gottesman MM, Pastan I, Roninson IB, Ling V, Riordan JR (1986) The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem Biophys Res Commun 141:956–962Google Scholar
  307. Ulrich E, Sey YM, Harrison RA, DeVito MJ (2008) LC/MS method for the analysis of permethrin enantiomers in biological matrices. 20th International Symposium on Chirality, Geneva, Switzerland, July 6–9, 2008.Google Scholar
  308. Unai T, Casida JE (1977) Synthesis of isomeric 3-(2,2-Dichlorovinyl)-2-hydroxymethyl-2-methylcyclopropanecarboxylic acids and other permethrin metabolites. J Agric Food Chem 25:979–987Google Scholar
  309. Valverde A, Aguilera A, Rodriguez M, Boulaid M (2001) What are we determining using gas chromatographic multiresidue methods: tralomethrin or deltamethrin? J Chromatogr A 943(1):101–111Google Scholar
  310. Van der Rhee HJ, Farquhar JA, Vermeulen NP (1989) Efficacy and transdermal absorption of permethrin in scabies patients. Acta Derm Venerol 69:170–173Google Scholar
  311. Varsho BJ (1996) Acute oral toxicity study of deltamethrin in albino rats. AgrEvo USA Company Study No. WIL-274001.Google Scholar
  312. Venkatakrishnan K, Von Moltke LL, Obach RS, Greenblatt DJ (2000) Microsomal binding of amitriptyline: effect on estimation of enzyme kinetic parameters in vitro. J Pharmacol Exp Ther 293:343–350Google Scholar
  313. Vistoli G, Pedretti A, Mazzolari A, Testa B (2010) In silico prediction of human carboxylesterase-1 (hCES1) metabolism combining docking analysis and MD simulations. Bioorg Med Chem 18:320–329Google Scholar
  314. Vozeh S, Taeschner W, Wenk M (1990) Pharmacokinetic drug data. In: Clinical pharmacokinetics drug data handbook. ADIS, Auckland, NZ. pp 1–38.Google Scholar
  315. Wadkins RM, Hyatt JL, Wei X, Yoon KJP, Wierdl M, Edwards CC, Morton CL, Obenauer JC, Damodaran K, Beroza P, Danks MK, Potter PM (2005) Identification and characterization of novel benzyl (diphenylethane-1,2-dione) analogues as inhibitors of mammalian carboxylesterases. J Med Chem 48:2906–2915Google Scholar
  316. Wang P, Zhou Z, Jiang S, Yang L (2004) Chiral resolution of cypermethrin on cellulose-tris(3,5-dimethylphenyl-carbamate) chiral stationary phase. Chromatographia 59:625–629Google Scholar
  317. Wang Q, Qiu J, Zhu W, Jia G, Li J, Bi C, Zhou Z (2006) Stereoselective degradation kinetics of theta-cypermethrin in rats. Environ Sci Technol 40:721–726Google Scholar
  318. Wang M, Wang Q, Hong C, Sleczka B, D’Arienzo C, Josephs J, Ye X-Y, Robl J, Gordon D, Rodrigues D, Harper T (2010) Prediction of in vivo enantiomeric compositions by modeling in vitro metabolic profiles. J Pharm Sci 99:3234–3245Google Scholar
  319. Waxman SG, Craner MJ, Black JA (2004) Na+ channel expression along axons in multiple sclerosis and its models. Trends Pharmacol Sci 25:584–591Google Scholar
  320. Weiner ML, Nemec M, Sheets L, Sargent D, Breckenridge (2009) Comparative functional observational battery study of twelve commercial pyrethroid insecticides in male rate following oral exposure. Neurotoxicology 30S:S1–S16Google Scholar
  321. Wester RC, Maibach HI (1977) In: Drill VA, Lazar P (eds) Cutaneous toxicology. Academic, New York, p 111Google Scholar
  322. Wester RC, Maibach HI (1993) Animal models for percutaneous absorption. In: Wang RGM, Knaak JB, Maibach HI (eds) Health risk assessment: dermal and inhalation exposure and absorption of toxicants. CRC, Boca Raton, FLGoogle Scholar
  323. Wester RC, Noonan PK (1980) Relevance of animal-moles for percutaneous-absorption. Int J Pharm 7:99–110Google Scholar
  324. Wester RC, Bucks DAW, Maibach HI (1994) Human in vivo percutaneous absorption of pyrethrin and piperonyl butoxide. Food Chem Toxicol 32:51–53Google Scholar
  325. Wheelock CE, Wheelock AM, Zhang R, Stok JE, Morisseau C, Le Valley SE (2003) Evaluation of alpha-cyanoesters as fluorescent substrates for examining interindividual variation in general and pyrethroid-selective esterases in human liver microsomes. Anal Biochem 315:208–222Google Scholar
  326. Wheelock CR, Miller JL, Miller MJ, Phillips BM, Huntley SA, Gee SJ, Tjeerdem RS, Hammock BD (2006) Use of carboxylesterase activity to remove pyrethroid-associated toxicity to Ceriodaphnia dubia and Hyalella azteca toxicity in identification evaluations. Environ Toxicol Chem 25:973–984Google Scholar
  327. White S (1994) Protein membrane structure. Oxford University Press, OxfordGoogle Scholar
  328. White INH, Verschoyle RD, Moradian MH, Barnes JM (1976) The relationship between brain levels of cismethrin and bioresmethrin in female rats and neurotoxic effects. Pestic Biochem Physiol 6:491–500Google Scholar
  329. WHO (2005a) WHO Specifications and evaluations for public health pesticides, Deltamethrin, (S)-a-cyano-3-phenoxybenzyl (1R,3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropane carboxylate. WHO, Genève.Google Scholar
  330. WHO (2005b) The WHO Recommended Classification of Pesticides by Hazard. Guidelines to Classification 2004, International Programme on Chemical Safety. WHO/PCS/01.5, Genève, http://www.who.int/ipcs/publications/pesticides_hazard/en/.
  331. WHO (World Health Organization) (1965) Evaluation of the toxicity of pesticide residues in food: dimethrin. FAO meeting report PL/1965/10/1. Food and Agriculture Organization (United Nations) www.inchem.org/documents/jmpr/jmpmono/v065pr21.htm
  332. Williams RL, Bernard CE, Krieger RI (2003) Human exposure to indoor residential cyfluthrin residues during a structured activity program. J Expo Anal Environ Epidemiol 13:112–119Google Scholar
  333. Wilson ZE, Rostami-Hodjegan A, Burn JL, Tooley A, Boyle J, Ellis SW, Tucker GT (2003) Inter-individual variability in levels of human microsomal protein and hepatocellularity per gram of liver. Br J Clin Pharmacol 56:433–440Google Scholar
  334. Wolansky MJ, Harrill JA (2008) Neurobehavioral toxicology of pyrethroid insecticides in adult animals: a critical review. Neurotoxicol Teratol 30:55–78Google Scholar
  335. Woollen BH, Marsh JR, Laird WJD, Lesser JE (1992) The metabolism of cypermethrin in man: differences in urinary profiles following oral and dermal administration. Xenobiotica 22:983–991Google Scholar
  336. Wu A, Liu Y (2003) Prolonged expression of c-Fos and c-Jun in the cerebral cortex of rats after deltamethrin treatment. Brain Res Mol Brain Res 110:147–151Google Scholar
  337. Xu C, Wang J, Liu W, Sheng GD, Tu Y, Ma Y (2007) Separation and aquatic toxicity of enantiomers of the pyrethroid insecticide Lambda-Cyhalothrin. Environ Toxicol Chem 27:174–181Google Scholar
  338. Yamamoto I, Elliot M, Casida JE (1971) Metabolic fate of pyrethrin I, pyrethrin II, and allethrin. Bull World Health Organ 44:347–348Google Scholar
  339. Yamazaki K, Kanaoka M (2004) Computational prediction of the plasma protein-binding percent of diverse pharmaceutical compounds. J Pharm Sci 93:1480–1494Google Scholar
  340. Yang J, Tucker GT, Rostami-Hodjegan A (2004a) Cytochrome P450 3A expression and activity in the human small intestine. Clin Pharmacol Ther 76:931Google Scholar
  341. Yang G-S, Vazquez PP, Frenich AG, Vidal JLM, Aboul-Enein HY (2004b) Separation on CHIRALCEL OD-R with methanol/water, and acetonitrile/water mobile phases. J Liq Chromatogr Rel Technol 27(10):1507–1521Google Scholar
  342. Yoon KJ-P, Krull EJ, Morton CL, Bornmann WG, Lee RE, Potter PM, Danks MK (2003) Activation of a camptothecin prodrug by specific carboxylesterases as predicted by quantitative structure-activity relationship and molecular docking studies. Mol Cancer Ther 2:1171–1181Google Scholar
  343. Youdim K, Dodia R (2010) Comparison between recombinant P450s and human liver microsomes in the determination of cytochrome P450 Michaelis–Menten constants. Xenobiotica 40:235–244Google Scholar
  344. Youdim KA, Zayed A, Dickins M, Phipps A, Griffiths M, Darekar A, Hyland R, Fahmi O, Hurst S, Plowchalk DR, Cook J, Guo F, Obach RS (2008) Application of CYP3a4 in vitro data to predict clinical drug-drug interactions: predictions of compounds as objects of interaction. Br J Clin Pharmacol 65:680–692Google Scholar
  345. Yu LX, Lipka E, Crison JR, Amidon GL (1996) Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption. Adv Drug Del Rev 19:359–376Google Scholar
  346. Zeng S, Tang Y (2009) Effect of clustered ion channels along an unmyelinated axon. Physical Rev E 80:1–9Google Scholar
  347. Zhang H (2005) A new approach for the tissue-blood partition coefficients of neutral and ionized compounds. J Chem Inf Model 45:121–127Google Scholar
  348. Zhang X, Tsang AM, Okino MS, Power FW, Knaak JB, Harrison LS, Dary CC (2007) A physiologically-based pharmacokinetic/pharmacodynamic (PBPK/PD) model for carbofuran in Sprague-Dawley rats using the Exposure Related Dose Estimating Model (ERDEM). Toxicol Sci 100:345–359Google Scholar
  349. Zhe X, Wenwei X, Hua H, Lirui P, Xu X (2008) Direct chiral resolution and its application to the determination of the pesticide tetramethrin in soil by high-performance liquid chromatography using polysaccharide-type chiral stationary phase. J Chromatogr Sci 46:783–786Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • James B. Knaak
    • 1
  • Curtis C. Dary
    • 2
  • Xiaofei Zhang
    • 3
  • Robert W. Gerlach
    • 3
  • R. Tornero-Velez
    • 4
  • Daniel T. Chang
    • 4
  • Rocky Goldsmith
    • 4
  • Jerry N. Blancato
    • 4
  1. 1.Department of Pharmacology and Toxicology, School of Medicine and Biomedical SciencesSUNY at BuffaloBuffaloUSA
  2. 2.Human Exposure and Atmospheric Sciences DivisionU.S. Environmental Protection AgencyLas VegasUSA
  3. 3.General Dynamics Information TechnologyHendersonUSA
  4. 4.National Exposure Research LaboratoryU.S. Environmental Protection AgencyResearch Triangle ParkUSA

Personalised recommendations